NU SKIN ENTERPRISES INC - A (NUS)
US67018T1051 - Common Stock
NUS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. NUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
In the past year NUS had a positive cash flow from operations.
Each year in the past 5 years NUS has been profitable.
Each year in the past 5 years NUS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of NUS (-9.36%) is worse than 74.29% of its industry peers.
The Return On Equity of NUS (-21.64%) is worse than 65.71% of its industry peers.
The Return On Invested Capital of NUS (2.44%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for NUS is below the industry average of 13.26%.
The 3 year average ROIC (9.55%) for NUS is well above the current ROIC(2.44%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.36% | ||
| ROE | -21.64% | ||
| ROIC | 2.44% |
ROA(3y)4.65%
ROA(5y)6.71%
ROE(3y)9.62%
ROE(5y)14.02%
ROIC(3y)9.55%
ROIC(5y)11.6%
1.3 Margins
NUS's Profit Margin has declined in the last couple of years.
NUS has a Operating Margin of 2.14%. This is comparable to the rest of the industry: NUS outperforms 48.57% of its industry peers.
NUS's Operating Margin has declined in the last couple of years.
NUS has a Gross Margin (67.58%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.14% | ||
| PM (TTM) | N/A | ||
| GM | 67.58% |
OM growth 3Y-29.77%
OM growth 5Y-21.55%
PM growth 3Y-61.1%
PM growth 5Y-37.43%
GM growth 3Y-2.56%
GM growth 5Y-2.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NUS is creating some value.
Compared to 1 year ago, NUS has about the same amount of shares outstanding.
The number of shares outstanding for NUS has been reduced compared to 5 years ago.
NUS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.29 indicates that NUS is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.29, NUS perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
NUS has a debt to FCF ratio of 4.28. This is a neutral value as NUS would need 4.28 years to pay back of all of its debts.
The Debt to FCF ratio of NUS (4.28) is better than 68.57% of its industry peers.
NUS has a Debt/Equity ratio of 0.62. This is a neutral value indicating NUS is somewhat dependend on debt financing.
NUS has a worse Debt to Equity ratio (0.62) than 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | 3.29 |
ROIC/WACC0.29
WACC8.51%
2.3 Liquidity
A Current Ratio of 2.12 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio (2.12) which is in line with its industry peers.
NUS has a Quick Ratio of 1.33. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, NUS is in line with its industry, outperforming 54.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
NUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.41%.
The earnings per share for NUS have been decreasing by -13.77% on average. This is quite bad
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.53%.
The Revenue has been decreasing by -5.97% on average over the past years.
EPS 1Y (TTM)-64.41%
EPS 3Y-20.41%
EPS 5Y-13.77%
EPS Q2Q%-69.64%
Revenue 1Y (TTM)-11.53%
Revenue growth 3Y-8.64%
Revenue growth 5Y-5.97%
Sales Q2Q%-13.76%
3.2 Future
NUS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.48% yearly.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.20% yearly.
EPS Next Y-57.75%
EPS Next 2Y-23.31%
EPS Next 3Y-7.48%
EPS Next 5YN/A
Revenue Next Year-10.37%
Revenue Next 2Y-4.13%
Revenue Next 3Y-1.2%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.60 indicates a reasonable valuation of NUS.
Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (29.20), we can say NUS is valued rather cheaply.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 6.67.
94.29% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (24.00), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 6.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
NUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.35 | ||
| EV/EBITDA | 5.16 |
4.3 Compensation for Growth
A cheap valuation may be justified as NUS's earnings are expected to decrease with -7.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.31%
EPS Next 3Y-7.48%
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 3.34%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of NUS has falen by -27.80%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
NUS's Dividend Yield is rather good when compared to the industry average which is at 4.93. NUS pays more dividend than 85.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, NUS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.34% |
5.2 History
The dividend of NUS has a limited annual growth rate of 1.01%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
NUS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.01%
Div Incr Years22
Div Non Decr Years22
5.3 Sustainability
NUS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-30.09%
EPS Next 2Y-23.31%
EPS Next 3Y-7.48%
NU SKIN ENTERPRISES INC - A
NYSE:NUS (11/22/2024, 8:04:00 PM)
After market: 7.22 0 (0%)7.22
-0.08 (-1.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap358.83M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.34% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 6.67 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.36% | ||
| ROE | -21.64% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 2.14% | ||
| PM (TTM) | N/A | ||
| GM | 67.58% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-64.41%
EPS 3Y-20.41%
EPS 5Y
EPS Q2Q%
EPS Next Y-57.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.53%
Revenue growth 3Y-8.64%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y